Craig is a solicitor in the Dispute Resolution team with a focus on patent litigation, primarily in the life sciences sector. He has experience of litigation in the High Court and the Court of Appeal in the UK and of coordinating parallel litigation across multiple jurisdictions in the context of global pharmaceutical life cycle management projects. Craig’s experience includes advising on disputes concerning formulation, process, second medical use and dosage regimen patents in the fields of small molecule pharmaceuticals (including enzyme inhibitors and immunomodulators), non-biological complex drugs, and biologics (both therapeutic antibodies and their biosimilars). On the non-contentious side, Craig has previously assisted clients with the IP aspects of life sciences M&A transactions and licensing agreements.
Outside of the life sciences sector Craig has worked on telecoms disputes involving SEP litigation and FRAND issues. He also has in-house experience, having spent six months on secondment to the group legal department of an international defence, aerospace and security company where he was involved with a wide range of corporate and commercial matters.
Before joining Carpmaels & Ransford in 2018, Craig trained at a Magic Circle firm and subsequently practised at one of London’s leading IP firms. Craig has a degree in Natural Sciences, specialising in Chemistry, from the University of Cambridge and a doctorate in Biochemistry from the University of Oxford.
- MSci Natural Sciences (Chemistry) (University of Cambridge)
- DPhil Biochemistry (University of Oxford)
- Diploma in IP Law & Practice (University of Oxford)
- UPC Representative